![Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019]()
by Admin | Jan 17, 2019 | News & Opinions
HOUSTON, Jan. 17, 2019 /PRNewswire/ — Marker Therapeutics, Inc. (Nasdaq: MRKR), a clinical-stage immuno-oncology company specializing in the development of next-generation T cell-based immunotherapies for the treatment of hematological malignancies and solid...
![Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019]()
by Admin | Jan 15, 2019 | News & Opinions
Sanford Health is a contributing partner of the 2019 World Stem Cell Summit. Philanthropist Denny Sanford received the RMF Stem Cell Action “Leadership” Award, at the 2013 World Stem Cell Summit in San Diego. It was his vision and focused philanthropy that...
![Marker Therapeutics to Present at the Phacilitate Leaders World & World Stem Cell Summit 2019]()
by Admin | Jan 15, 2019 | News & Opinions
Who owns the brand “stem cells” ? Lofty scientific societies, such as the International Society for Stem Cell Research (ISSCR)? How about medical associations like the American Society for Plastic Surgeons (ASPS) or members of the International Federation...
by Admin | Jan 10, 2019 | News & Opinions
MIAMI – May 23, 2018 – Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for age-related diseases, announced that it is currently recruiting for a Phase 1 clinical trial to evaluate the safety and efficacy of its allogeneic Mesenchymal Stem...
by Admin | Jan 10, 2019 | News & Opinions
Grant will be applied to Longeveron’s Aging Frailty stem cell research MIAMI, Oct. 18, 2018 – Longeveron LLC, a biopharmaceutical company that develops stem cell therapies for aging-related diseases, announced that the company has been awarded a $3.8 million Small...
